APA (7th ed.) Citation

K, T., A, H., D, F., RM, L., BD, J., B, K., & RW, S. (2026). Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies. Communications medicine, 6(1), . https://doi.org/10.1038/s43856-026-01680-w

Chicago Style (17th ed.) Citation

K, Tao, Herschhorn A, Fera D, Lynch RM, Julg BD, Korber B, and Shafer RW. "Genotypic Challenges in Implementing Broadly Neutralizing Antibody-based Long-acting HIV-1 Therapies." Communications Medicine 6, no. 1 (2026). https://doi.org/10.1038/s43856-026-01680-w.

MLA (9th ed.) Citation

K, Tao, et al. "Genotypic Challenges in Implementing Broadly Neutralizing Antibody-based Long-acting HIV-1 Therapies." Communications Medicine, vol. 6, no. 1, 2026, https://doi.org/10.1038/s43856-026-01680-w.